Improved technic for preparing a buried dermal graft in hernial repair

1944 ◽  
Vol 66 (2) ◽  
pp. 249-251 ◽  
Author(s):  
James V. Scola
Keyword(s):  
2021 ◽  
pp. 000313482110233
Author(s):  
Jordan Robinson ◽  
Jesse K. Sulzer ◽  
Benjamin Motz ◽  
Erin H. Baker ◽  
John B. Martinie ◽  
...  

Background Abdominal wall reconstruction in high-risk and contaminated cases remains a challenging surgical dilemma. We report long-term clinical outcomes for a rifampin-/minocycline-coated acellular dermal graft (XenMatrix™ AB) in complex abdominal wall reconstruction for patients with a prior open abdomen or contaminated wounds. Methods Patients undergoing abdominal wall reconstruction at our institution at high risk for surgical site occurrence and reconstructed with XenMatrix™ AB with intent-to-treat between 2014 and 2017 were included. Demographics, operative characteristics, and outcomes were collected. The primary outcome was hernia recurrence. The secondary outcomes included length of stay, surgical site occurrence, readmission, morbidity, and mortality. Results Twenty-two patients underwent abdominal wall reconstruction using XenMatrix™ AB during the study period. Two patients died while inpatient from progression of their comorbid diseases and were excluded. Sixty percent of patients had an open abdomen at the time of repair. All patients were from modified Ventral Hernia Working Group class 2 or 3. There were a total of four 30-day infectious complications including superficial cellulitis/fat necrosis (15%) and one intraperitoneal abscess (5%). No patients required reoperation or graft excision. Median clinical follow-up was 38.2 months with a mean of 35.2 +/− 18.5 months. Two asymptomatic recurrences and one symptomatic recurrence were noted during this period with one planning for elective repair of an eventration. Follow-up was extended by phone interview which identified no additional recurrences at a median of 45.5 and mean of 50.5 +/−12.7 months. Conclusion We present long-term outcomes for patients with high-risk and contaminated wounds who underwent abdominal wall reconstruction reinforced with XenMatrix™ AB to achieve early, permanent abdominal closure. Acceptable outcomes were noted.


2002 ◽  
Vol 28 (2) ◽  
pp. 122-126
Author(s):  
KERSTIN QUERINGS ◽  
DIETER BACHTER ◽  
BERND-RÜDIGER BALDA
Keyword(s):  

2015 ◽  
Vol 31 (3) ◽  
pp. 291-295 ◽  
Author(s):  
Le Tan Son ◽  
Le Thanh Hung ◽  
Le Cong Thang ◽  
Nguyen Thi Truc Linh

1980 ◽  
Vol 55 (3) ◽  
pp. 385-387 ◽  
Author(s):  
Marco Antonio Pelosi ◽  
Joseph Apuzzio ◽  
Vijaya Gowda ◽  
Ramesh C. Patel

Sign in / Sign up

Export Citation Format

Share Document